accur
diagnosi
chaga
diseas
import
parasit
diseas
america
challeng
due
latent
charact
infect
follow
brief
acut
phase
infect
individu
progress
lifelong
chronic
phase
eventu
develop
typic
cardiac
intestin
complic
fatal
trypanosoma
cruzi
protozoan
pathogen
agent
natur
transmit
blood
suck
triatomina
bug
addit
transmiss
rout
includ
vertic
transmiss
mother
child
transfus
infect
blood
organ
transplant
oral
cruzi
transmiss
consumpt
contamin
food
link
local
outbreak
acut
chaga
diseas
cruzi
speci
genet
heterogen
classifi
two
major
phylogenet
lineag
cruzi
cruzi
ii
latter
subdivid
sublineag
iia
iie
cruzi
predomin
endem
countri
north
amazon
wherea
cruzi
ii
predomin
throughout
southern
cone
countri
south
america
cruzi
associ
domest
sylvat
transmiss
cycl
iia
iic
seem
restrict
sylvat
cycl
iib
iid
iie
domest
cycl
lineag
associ
cardiac
lesion
human
infect
seem
digest
tract
lesion
occur
infect
cruzi
ii
cruzi
close
relat
rang
appar
harmless
man
share
reservoir
anim
vector
acut
infect
although
rare
recogn
nonspecif
clinic
manifest
diagnos
parasitolog
test
sinc
parasit
load
blood
stage
gener
high
enough
chronic
infect
contrari
associ
low
parasit
load
blood
therefor
mainli
diagnos
mean
antibodi
detect
test
howev
antibodi
detect
test
liabl
specif
problem
due
crossreact
antibodi
induc
parasit
especi
leishmania
rang
henc
gener
recommend
specimen
test
two
three
differ
immunodiagnost
test
indirect
immunofluoresc
iif
indirect
hemagglutin
iha
enzymelink
immuno
sorbent
assay
elisa
furthermor
immunodiagnost
test
less
use
test
effect
treatment
congenit
infect
xenodiagnosi
regularli
use
parasit
detect
result
invas
test
avail
month
method
show
gener
low
sensit
chronic
infect
accur
tool
rapidli
diagnos
activ
infect
assess
treatment
efficaci
determin
impact
transmiss
control
measur
need
introduct
polymeras
chain
reaction
pcr
amplifi
specif
dna
sequenc
open
promis
diagnost
perspect
pcr
use
detect
cruzi
blood
chronic
chagas
patient
congenit
transmiss
patient
followup
treatment
diseas
reactiv
heart
transplant
despit
report
high
sensit
specif
pcr
techniqu
restrict
highlevel
equip
laboratori
partli
due
labori
timeconsum
detect
pcr
product
amplicon
gener
detect
electrophoresi
agaros
gel
follow
uv
illumin
presenc
carcinogen
ethidium
bromid
quantit
realtim
detect
pcr
amplifi
cruzi
dna
develop
offer
major
advantag
increas
sensit
highthroughput
analysi
singl
tube
format
howev
techniqu
complex
expens
besid
need
simplif
dna
amplif
assay
standard
crucial
requir
move
molecular
tool
toward
patient
diagnosi
diseas
control
oligochromatographi
oligoc
provid
simpl
rapid
onestep
dipstick
format
detect
pcr
product
cori
bioconcept
gembloux
belgium
patent
wo
pcr
step
detect
step
take
minut
equip
water
bath
pipett
need
control
pcr
reaction
chromatograph
migrat
incorpor
assay
techniqu
alreadi
develop
diagnosi
human
african
trypanosomiasi
leishmaniasi
toxoplasmosi
schistosomiasi
sever
acut
respiratori
syndrom
sar
high
sensit
specif
report
describ
develop
phase
evalu
cruzi
pcroligochromatographi
test
cruzi
oligoctest
target
highli
conserv
satellit
dna
sequenc
assess
diagnost
accuraci
assay
broad
spectrum
biolog
sampl
chaga
nonendem
endem
control
person
infect
children
adult
reservoir
anim
vector
cruzi
lineag
iib
epimastigot
grown
glucoselactalbumineserumhemoglobin
glsh
medium
fetal
calf
serum
day
postinocul
parasit
count
count
chamber
marienfeld
germani
tenfold
dilut
seri
parasit
rang
blood
made
human
blood
freshli
taken
edta
healthi
volunt
nonspik
blood
use
neg
control
purifi
dna
cruzi
ivv
rn
pcr
belong
lineag
iia
iib
iic
iid
iie
respect
obtain
dna
refer
bank
institut
tropic
medicin
antwerp
itma
belgium
dna
differ
trypanosoma
rang
isol
tabl
leishmania
donovani
trypanosoma
brucei
gambiens
mycobacterium
tuberculosi
schistosoma
mansoni
plasmodium
falciparum
obtain
research
group
dna
concentr
measur
nanodrop
uvvi
spectrophotomet
nanodrop
technolog
wilmington
usa
dna
store
dna
extract
blood
confirm
brucei
gambiens
infect
person
democrat
republ
congo
drc
confirm
l
donovani
infect
person
nepal
confirm
p
falciparum
infect
person
zambia
obtain
collect
depart
parasitolog
itma
infect
confirm
direct
parasit
detect
blood
tissu
aspir
blood
sampl
chaga
endem
control
person
obtain
blood
bank
clinic
hospit
univers
chile
blood
bank
sampl
classifi
infect
cruzi
neg
two
differ
antibodi
detect
tool
iif
elisa
ml
whole
blood
children
year
old
adult
year
old
infect
cruzi
collect
chile
region
iv
year
blood
mix
equal
volum
guanidinehcl
edta
subject
dna
extract
person
consid
infect
cruzi
posit
kdna
pcr
amplifi
minicircl
variabl
region
follow
southern
blot
hybrid
cruzi
specif
probe
describ
zulantay
et
al
adult
chaga
diseas
patient
clinic
serolog
xenodiagnosi
data
avail
six
patient
show
normal
electrocardiogram
ecg
result
show
prolong
qtc
syndrom
one
show
sinu
tachycardia
patient
ecg
done
patient
posit
two
independ
immunodiagnost
test
iif
elisa
patient
neg
xenodiagnosi
show
posit
result
kdna
pcr
perform
xenodiagnosi
specimen
blood
octodon
degu
abrothrix
olivaceu
rodent
intestin
content
mepraia
spinolai
bug
collect
anim
origin
la
chinchilla
nation
reserv
chile
region
iv
classifi
infect
cruzi
base
posit
result
kdna
pcr
follow
southern
blot
hybrid
dna
cruzi
cultur
extract
qiaamp
dna
mini
kit
qiagen
hilden
germani
spike
blood
blood
endem
control
person
extract
use
qiaamp
dna
blood
mini
kit
qiagen
hilden
germani
dna
blood
patient
anim
extract
ezna
blood
dna
kit
omega
bioteck
inc
doravil
ga
intestin
content
vector
mix
pb
boil
minut
centrifug
g
supernat
use
dna
templat
sequenc
bp
cruzi
satellit
dna
genbank
access
number
align
use
dna
man
softwar
lynnon
corpor
quebec
canada
sens
primer
tcsatf
antisens
primer
tcsatr
design
target
conserv
bp
sequenc
within
cruzi
satellit
dna
antisens
primer
tcsatr
biotinyl
end
intern
control
ic
dna
sequenc
bp
ident
cruzi
target
sequenc
except
bp
central
part
ic
central
sequenc
design
length
gc
content
cruzi
central
sequenc
cruzi
detect
probe
ic
detect
probe
design
hybrid
cruzi
ic
central
sequenc
respect
detect
probe
conjug
gold
particl
use
procedur
describ
patent
wo
cruzi
ic
migrat
control
probe
synthes
revers
complement
sequenc
respect
detect
probe
pcr
reaction
mixtur
prepar
ad
sampl
dna
unit
hot
star
taq
polymeras
qiagen
hilden
germani
cruzi
amplimix
cori
bioconcept
gembloux
belgium
premad
pcr
mix
contain
compon
allow
pcr
amplif
primer
tcsatf
tcsatr
ic
dna
concentr
commonli
use
dttp
replac
dutp
allow
elimin
carryov
contamin
uracyldna
nglycosilas
initi
denatur
step
minut
activ
hot
star
taq
polymeras
follow
cycl
second
second
second
final
extens
minut
amplif
carri
thinwal
pcr
tube
abgen
epsom
unit
kingdom
thermocycl
biometra
germani
cruzi
oligostrip
construct
principl
hatpcroc
dipstick
describ
deborggraev
et
al
migrat
control
line
ad
test
side
schemat
overview
cruzi
oligoctest
principl
present
figur
ic
line
migrat
control
line
determin
whether
cruzi
oligoc
test
valid
invalid
invis
migrat
control
line
indic
invalid
detect
step
invalid
pcr
reaction
indic
neg
ic
line
combin
neg
test
line
latter
may
happen
due
inhibitori
factor
extract
dna
assay
repeat
control
line
indic
failur
migrat
pcr
reaction
sampl
contain
high
concentr
cruzi
dna
competit
cruzi
ic
templat
dna
result
invis
ic
control
line
combin
strongli
visibl
cruzi
test
line
case
test
result
consid
valid
posit
result
pcr
amplif
pcr
product
denatur
second
transfer
immedi
ice
forti
microlit
mix
equal
volum
oligostrip
run
buffer
preheat
follow
dip
cruzi
oligostrip
solut
test
result
read
minut
qualit
whenev
test
line
appear
visibl
nake
eye
test
consid
posit
test
result
read
oligostrip
store
futur
read
background
may
appear
dri
strip
detect
limit
cruzi
oligoctest
evalu
three
independ
tenfold
serial
dilut
cruzi
strain
dna
water
contain
mgml
acetyl
bovin
serum
albumin
bsa
lower
detect
limit
consist
fg
dna
per
assay
figur
dna
content
one
parasit
analyt
sensit
also
evalu
dna
extract
three
independ
blood
sampl
seri
spike
decreas
number
live
cruzi
epimastigot
assay
abl
detect
parasit
blood
sampl
figur
nonspik
control
blood
sampl
alway
remain
neg
analyt
specif
assay
evalu
tenfold
serial
dilut
dna
cruzi
strain
repres
differ
lineag
dna
relev
non
target
pathogen
cruzi
oligoctest
abl
detect
fg
dna
strain
lineag
iic
rn
pcr
iid
iie
fg
dna
strain
stc
iia
ivv
iib
pg
dna
strain
neg
test
result
observ
ng
purifi
dna
per
test
l
donovani
brucei
gambiens
tuberculosi
mansoni
p
falciparum
assess
level
rang
detect
cruzi
oligoctest
tenfold
serial
dilut
purifi
dna
differ
rang
isol
test
tabl
four
rang
isol
could
detect
dna
concentr
pg
per
assay
dna
concentr
pg
ng
isol
remain
neg
test
ng
dna
per
assay
neg
result
observ
test
dna
extract
blood
brucei
gambiens
infect
person
drc
l
donovani
infect
person
nepal
p
falciparum
infect
person
zambia
chaga
endem
control
blood
sampl
chile
tabl
henc
specif
assay
chaga
nonendem
endem
control
blood
sampl
confid
interv
ci
score
wilson
method
diagnost
accuraci
cruzi
oligoctest
test
biolog
sampl
cruzi
infect
children
infect
adult
infect
degu
rodent
infect
alivaceu
rodent
infect
spinolai
bug
tabl
sampl
show
posit
test
result
except
blood
sampl
children
henc
test
show
sensit
ci
ci
ci
specimen
infect
children
adult
rodent
vector
respect
two
oligoctest
neg
blood
sampl
show
invalid
result
two
independ
repetit
therefor
dna
ethanol
precipit
wash
describ
elsewher
purifi
dna
sampl
retest
cruzi
oligoctest
valid
neg
test
result
observ
antibodi
detect
routin
use
diagnosi
chaga
diseas
suffer
specif
problem
crossreact
antibodi
infecti
agent
leishmania
spp
rang
furthermor
immunodiagnosi
less
use
cure
assess
treatment
diagnosi
congenit
transmiss
xenodiagnosi
cumbersom
time
consum
invas
molecular
detect
parasit
pcr
techniqu
abl
overcom
drawback
sinc
high
sensit
specif
combin
detect
dna
surrog
parasit
detect
despit
major
advantag
pcr
still
restrict
research
applic
enter
mani
diagnost
laboratori
yet
mainli
due
complex
techniqu
furthermor
numer
hous
diagnost
pcr
assay
neglect
standard
hamper
promis
techniqu
occupi
major
posit
clinic
diagnosi
next
patient
manag
pcr
play
import
role
accur
surrog
parasit
detect
epidemiolog
studi
reservoir
anim
vector
studi
molecular
dipstick
assay
simpl
rapid
standard
detect
cruzi
dna
develop
evalu
cruzi
oligoctest
consist
pcr
amplif
short
sequenc
within
cruzi
satellit
dna
follow
singl
step
pcr
product
detect
dipstick
format
detect
step
perform
minut
equip
need
pipett
water
bath
lower
detect
limit
assay
fg
purifi
cruzi
strain
dna
parasit
blood
sampl
similar
detect
limit
primer
target
bp
satellit
dna
report
moser
et
al
diaz
et
al
respect
howev
test
serial
dilut
dna
cruzi
strain
repres
lineag
observ
time
lower
sensit
cruzi
strain
lineag
compar
strain
lineag
ii
lower
sensit
cruzi
lineag
probabl
due
lower
copi
number
satellit
repeat
lineag
report
elia
et
al
confirm
fact
diaz
et
al
also
observ
lower
sensit
primer
dna
cruzi
strain
test
show
posit
signal
test
purifi
dna
rang
assess
level
crossreact
serial
dilut
seri
dna
differ
rang
isol
test
four
isol
could
detect
pg
dna
per
test
time
requir
dna
cruzi
lineag
time
cruzi
lineag
ii
fourteen
rang
isol
requir
higher
amount
dna
detect
cruzi
oligctest
remain
neg
ng
dna
per
assay
contrast
och
et
al
virreira
et
al
report
amplif
rang
dna
primer
howev
author
use
one
rang
isol
one
dna
concentr
observ
crossreact
rang
surpris
sinc
satellit
dna
describ
rang
brenier
et
al
report
number
repeat
bp
satellit
dna
far
lower
rang
cruzi
might
explain
higher
detect
threshold
assay
rang
variabl
rang
detect
level
probabl
due
variabl
copi
number
satellit
repeat
within
rang
popul
describ
cruzi
howev
parasitaemia
rang
parasit
per
ml
blood
human
unlik
sinc
sever
studi
report
low
rang
multipl
mammalian
host
cell
specif
cruzi
oligoctest
estim
blood
sampl
chaga
nonendem
endem
control
person
sensit
infect
patient
infect
rodent
infect
vector
observ
high
sensit
blood
sampl
adult
encourag
given
gener
low
parasitaemia
blood
patient
howev
use
kdna
pcr
follow
southern
blot
main
refer
test
instead
immunodiagnosi
current
standard
diagnost
techniqu
chronic
chaga
diseas
adult
patient
addit
diagnost
test
result
avail
show
posit
immunodiagnost
test
result
neg
convent
xenodiagnosi
indic
high
sensit
pcr
base
parasit
detect
evalu
need
estim
diagnost
accuraci
test
chronic
chagas
patient
diagnos
basi
immunodiagnost
tool
alon
neg
result
two
blood
sampl
children
unexpect
sinc
parasit
load
gener
higher
children
adult
two
sampl
show
initi
invalid
cruzi
oligoctest
result
indic
inhibit
pcr
reaction
therefor
dna
precipit
wash
retest
cruzi
oligoctest
test
becam
valid
neg
dna
might
lost
multipl
purif
step
test
show
high
sensit
reservoir
anim
vector
promis
regard
coexist
differ
cruzi
lineag
includ
lineag
collect
site
report
roza
et
al
conclus
diagnost
accuraci
divers
panel
biolog
sampl
indic
potenti
cruzi
oligoctest
phase
ii
iii
evalu
studi
need
assess
diagnost
sensit
specif
test
human
target
popul
differ
endem
region
person
potenti
crossreact
diseas
leishmaniasi
includ
control
group
futur
phase
ii
evalu
new
tool
first
step
toward
lowtech
userfriendli
molecular
diagnost
cruzi
detect
besid
simplif
present
cruzi
oligoctest
selfcontain
kit
readytous
pcr
mix
dipstick
offer
excel
prospect
pcr
standard
standard
pcr
techniqu
crucial
implement
refer
parasit
detect
test
diagnosi
clinic
studi
chaga
diseas
routin
diagnos
antibodi
detect
simpl
standard
pcr
format
play
import
role
situat
use
immunodiagnosi
limit
congenit
chaga
diseas
patient
followup
treatment
diseas
reactiv
organ
transplant
addit
potenti
nich
cruzi
oligoctest
may
patient
acut
chaga
diseas
neg
test
result
direct
microscopi
patient
chronic
chaga
diseas
inconsist
borderlin
immunodiagnost
test
result
isotherm
amplif
parasit
dna
novel
method
loop
mediat
isotherm
amplif
lamp
nucleic
acid
sequenc
base
amplif
nasba
might
simplifi
assay
furthermor
standard
pcr
format
discrimin
lineag
cruzi
would
welcom
sinc
accur
lineag
discrimin
import
diseas
vector
control
programm
addit
standard
sampl
procedur
dna
extract
need
well
conclus
cruzi
oligoctest
repres
simplifi
standard
pcr
format
cruzi
detect
biolog
sampl
innov
assay
bear
clear
potenti
simplifi
molecular
diagnost
tool
chaga
diseas
midlevelequip
laboratori
